Article Text
PDFFiller
Single blind placebo in drug research
Statistics from Altmetric.com
sir
The recent article by Evans in the journal on the single blind placebo in drug research is timely and its conclusions were persuasive. The basic premiss that single blind placebo “washout” periods are ethically specious was well argued and I agree that from a scientific point of view they have no valid justification. The real reasons …
Read the full text or download the PDF:
Other content recommended for you
- Justified deception? The single blind placebo in drug research
- Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study
- Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER* study
- Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points
- Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study
- Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review
- Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)
- The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
- Meta-analysis of short term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis
- Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial